The development of effective strategies for gene therapy has been hampered by difficulties verifying transgene delivery in vivo and quantifying gene expression non-invasively. Magnetic resonance imaging (MRI) offers high spatial resolution and three-dimensional views, without tissue depth limitations. The iron-storage protein ferritin is a prototype MRI gene reporter. Ferritin forms a paramagnetic ferrihydrite core that can be detected by MRI via its effect on the local magnetic field experienced by water protons. In an effort to better characterize the ferritin reporter for central nervous system applications, we expressed ferritin in the mouse brain in vivo using a neurotropic herpes simplex virus type 1 (HSV-1). We computed three-dimensional maps of MRI transverse relaxation rates in the mouse brain with ascending doses of ferritin-expressing HSV-1. We established that the transverse relaxation rates correlate significantly to the number of inoculated infectious particles. Our results are potentially useful for quantitatively assessing limitations of ferritin reporters for gene therapy applications.
INTRODUCTION
Evaluating the success of gene therapy requires accurate information about the vector bio-distribution and the efficacy of gene transfer. 1 Improving gene transfer potentially involves increasing vector dose; however, this risks vector-induced tissue toxicity and immunogenicity. 2 Thus, it is important to establish the degree of vector distribution in the target tissue and the minimal viral load that will achieve the desired delivery objective. 3 Efforts to measure the expression levels of therapeutic transgenes have characteristically relied on tissue-destructive methods. However, analysis of tissue sections may not accurately represent gene expression throughout the whole organ. Moreover, as traditional assays require sacrificing the organism, time-course studies often require large animal numbers.
Non-invasive imaging of reporter genes provides an alternative to traditional methods, and there are ongoing efforts to relate image properties to actual expression levels in target tissues. 4, 5 Non-invasive imaging techniques enable longitudinal studies, thereby reducing the total number of animals needed and provides information about expression dynamics in individuals. Many studies have focused on real-time optical imaging of fluorescent and bioluminescent reporters such as green fluorescent protein (GFP) and luciferase. 6, 7 Optical reporters provide high spatial and temporal resolution. Attenuation of light in tissues restricts the penetration depth and confines in vivo experiments to mostly superficial regions. 8 Optical reporters with longer wavelengths can improve depth penetration; however, light absorption and scatter in tissues limits quantitative imaging. 7, 8 Luciferase imaging is inherently difficult to quantify robustly, as it requires the addition of an exogenous substrate and, furthermore, the signal depends on local oxygen and ATP concentrations. 9 Positron emission tomography (PET) and single photon emission tomography (SPECT) reporters are intrinsically quantitative. 10 Although these methods have high sensitivity and are not limited by depth penetration, there are several drawbacks. Both PET and SPECT yield relatively low-resolution images and generally must be co-registered with images from other modalities, such as computerized tomography or magnetic resonsnce imaging (MRI), for anatomical reference. Also, due to radioactive decay, longitudinal studies can be performed only at time points that are far apart, 11 and in humans the ionizing radiation places limits on the imaging frequency.
Significant research activity in MRI and magnetic resonance spectroscopy (MRS) has centered on the development of gene reporters. MRI is inherently 3D, has high spatial resolution, and there is no image depth limitation. In addition, MRI and MRS can provide multi-parametric data of biological significance that can be combined in the same image space to yield anatomical and physiological context. In contrast to PET and SPECT studies, MRI does not use ionizing radiation and is well suited for longitudinal studies.
There are several emerging MRI reporter technology platforms, and these can be coupled to genes of interest, 12 such as a therapeutic. For example, the expression and activity of the enzyme cytosine deaminase has been imaged using 19 F MRI or detected with MRS. 13 Imaging cytosine deaminase generally relies on the enzyme interaction with an exogenous substrate bound to an imaging probe or a prodrug. The results depend on the probe distribution in tissues, its cellular uptake at the site of the enzymatic activity, and enzyme-substrate kinetics under different physiological conditions. In another example, 31 P MRS has been used to measure the transgene expression of creatine kinase transgene reporters has to take into account the native expression of these enzymes, 16 as well as the abundance of their substrates. The iron-storage protein ferritin has been successfully used as a 'probeless' MRI reporter gene in both vector-mediated gene delivery and transgenic animal models. [17] [18] [19] [20] [21] [22] [23] [24] Upon transgene expression, ferritin loads iron in situ and stores it in a paramagnetic ferrihydrite core. 18 The net magnetic moment of this core affects the transverse relaxation rates (R 2 ¼ 1/T 2 and R 2 * ¼ 1/T 2 *) of nearby water protons, thereby imparting hypointensity to T 2 -and T 2 *-weighted images. 25 However, quantifying ferritin levels based on proton images is indirect, and using T 2 and T 2 * relaxation rates to measure levels can be confounded by intrinsic background variations of these parameters and imprecise knowledge of the reporter's potency (i.e., relaxivity) in vivo. 26 Nonetheless, the use of ferritin as an MRI gene reporter has several advantages-it is expressed from a simple genetic construct, does not require an exogenous substrate, and is relatively non-toxic. 27 Recently, a 'second generation' ferritin-based reporter was developed with enhanced sensitivity. 28 Overall, ferritin reporters are positioned to be an alternative to optical and radioisotope probes for the preclinical development of gene therapy protocols.
Viral vectors, commonly used for therapeutic gene delivery, introduce an additional set of variables when used to express MRI reporters. Reporter expression can depend on the type of virus, its biodistribution, cell tropism, genome behavior, and tissue toxicity. A recent study evaluated ferritin expression mediated by lentivirus and adeno-associated viral vectors and addressed some of these issues, where the authors determined that adeno-associated viral vectors were superior to lentivirus vectors as they generated less background contrast owing to inflammation. 29 In the present study, we characterize the herpes simplex virus type 1 (HSV-1) as a vector system for the expression of the ferritin reporter. HSV-1 is a vector with a high transgene payload and has been used for gene therapy in diseases of the nervous system. 30 HSV-1 is neurotropic and can deliver transgenes with high cell specificity. 31 In addition, engineered HSV-1 vectors have low immunogenicity, and depending on promoter, they are capable of long-term transgene expression. 32 In this paper, we characterize HSV-1-mediated ferritin expression in the mouse central nervous system (CNS). Following HSV-1 inoculation into the CNS, we use an indirect method of quantifying gene reporter expression based on the local transverse relaxation rates (R 2 and R 2 *). The increase in R 2 and R 2 * at the site of ferritin expression were correlated to the number of HSV-1 particles injected. We empirically established the lower limits of viral dose required to produce readily discernible MRI detectability. Overall, we show that HSV-1 ferritin expression is potentially a viable approach for visualizing gene transfer into the CNS. Figure 1a shows a diagram of the HSV-1 constructs used in this study. We utilized a HSV-1 replication incompetent vector 33 to express human heavy chain ferritin (HFt) and enhanced GFP (eGFP) under the control of a cytomegalovirus promoter. The control vector was isogenic except that it expressed LacZ instead of ferritin. (Figure 1a, top) .
RESULTS

Characterization of HSV-1 MRI reporter system in vitro
We used western blot and immunofluorescence to verify HFt reporter expression in a mammalian (B103) cell line (Figures 1b  and c) . HSV-1 expression of reporter genes targets neuronal cell populations HSV-1 is reported to display a strong transduction propensity for neurons over glia. 31 Thus, we evaluated whether expression of the HFt reporter was present within CNS neurons following vector injection. We used immunohistochemistry to confirm the phenotype of the HSV-1-transduced cells expressing the MRI reporter. Cells expressing eGFP were detected on both the HFt and the LacZ control injection sites, and these same cells also stained positively for the neurofilament neuronal marker (Figure 4a ). The cells on the MRI reporter side showed strong colocalization of eGFP and HFt (Figure 4b ).
Correlation between transverse relaxation rate and inoculated HSV-1 HFt dose We examined the relationship between MRI reporter detectability and the number of CNS-inoculated HSV-1 particles. Expression of HFt resulted in substantial MRI contrast that was stronger at higher viral doses (Figures 5a and c). The R 2 and R 2 * maps showed a pronounced increase in the relaxation rate at the site of vector inoculation, and the results from a representative animals injected with different number of viral particles are shown in Figures 5b and d. To quantify reporter expression, we delineated 3D regions encompassing the injection sites and used the distribution of the local relaxation rates to calculate the mean relaxation rate in the volume displaying reporter expression. The same procedure was performed for the contralateral injection site ( Figure 5, asterisks) .
We applied a linear regression model to correlate the mean relaxation rates to the number of inoculated viral particles (Figure 6a) . We fit the data to the linear model y ¼ a À b Â x with no weighting of separate data points. The parameters that best characterized the relationship of R 2 to number of inoculated particles were a ¼ 19. . This linear correlation yielded a goodness of fit of R 2 ¼ 0.76 and P ¼ 0.0002 at a 95% confidence interval. For R 2 * relaxation rates, the corresponding values were R 2 ¼ 0.65 and P ¼ 0.0015. In order to confirm the validity of the linear model, we applied the Shapiro-Wilk normality test to the residuals of the linear regression for both the mean R 2 and R 2 *. The distribution of the residuals passed the normality test in both cases (Po0.05); however, for R 2 *, it was significant by a very small margin. In order to refine the fit, we applied an exponential saturation model to the same datasets and the results are shown in Figure 6b .
The goodness for the exponential saturation fit was higher, with R 2 ¼ 0.78 and 0.91 for R 2 and R 2 *, respectively.
Evaluation of the sensitivity of HSV-mediated ferritin expression In order to establish the sensitivity limit of our HSV-1 viral construct, we compared the mean relaxation rates of the 3D regions transduced with HFt reporter with the mean rates within volumes containing the LacZ injections ( Figure 7 ). Using R 2 , an inoculation of 25 Â 10 6 viral particles was sufficient to distinguish between reporter gene and control ( Figure 7a) ; however, as expected, R 2 * was more sensitive to HFt expression, and 12.5 Â 10 6 particles yielded a sufficient change in the relaxation rate at the site of injection to provide significant differences between the expression of HFt and LacZ. Also, the difference between the mean R 2 from the regions expressing HFt and LacZ was approximately 10-15%, whereas the corresponding difference in R 2 * was 30-40%. In control regions of interest (ROI), the average values of R 2 and R 2 * were 17.6 ± 0.53 s À 1 and 18.9 ± 0.55 s À 1 , respectively. In all the cases, the mean transverse relaxation rates for volumes containing the LacZ injection did not differ significantly.
DISCUSSION
Viral vectors used as gene transfer vehicles are indispensable tools
in preclinical studies and are becoming prevalent in gene therapy clinical trials. Gene therapy has been hampered by the lack of noninvasive tools for evaluating therapeutic gene expression and biodistribution. Our study addresses the need for non-invasive visualization of gene expression in live animals. In the case of viral injections in brain tissue, secondary events such as hemorrhage around the needle track, viral toxicity, and immune cell infiltration can potentially result in MRI contrast changes at the injection sites, including the control vector. 29 Such contrast changes could be erroneously interpreted as ferritin-induced hypointensity. For example, using phosphate-buffered saline as a negative control does not take into account the contrast owing to the viral toxicity of the expressing vector. Thus, we used a control that uses an isogenic vector, with the only difference being a substitution of LacZ for ferritn at the same locus (Figure 1a) . The choice of a minimally toxic vector can greatly improve the results. Thus, we used a well-characterized recombinant HSV-1 vector that is replication defective and relatively non-toxic. 33 Using the hematoxylin and eosin histology, we did not observe evidence of tissue toxicity or the significant presence of red blood cells indicative of hemorrhaging (Figure 3a ). Hematoxylin and eosin stain showed pronounced blue color around the site of reporter injection (Figure 3a) . Ferric ions bind to unoxidized hematoxylin forming chelate complexes with blue-black color. 34 This reaction is utilized by the classic Heidenhein iron hematein stain and it serves as an additional histochemical evidence of local iron accumulation. 35 Successful in vivo applications using viral vectors rely on the availability of high viral titers, purification of the inoculum from the immunogenic viral debris, and targeting susceptible cells. In the present work, we used purified, high-titer stocks of HSV-1 and confirmed its strong neurotropism in vivo using immunohistochemistry (Figures 4a and c) .
We correlated changes in transverse relaxation rates owing to HFT expression in the mouse brain to the number of inoculated HSV-1 particles (Figure 6 ). Similar indirect quantification methods have been used for non-invasive measurements of gene expression. For example, PET was used to monitor HSV-tk expression after intratumoral injection with adenovirus and showed that the signal from the 18 F ligand was linearly dependent on the injected viral dose. 36 A recent study using ferritin as a MRI reporter in metastatic melanoma cells also used indirect quantification by correlating ferritin relaxation rates to the histological volume of the metastatic tumor. 37 Although the ultimate goal for monitoring gene therapy is to achieve absolute measurements of molecular concentrations, 38, 39 semi-quantitative and indirect measurements are important initial developments. 5 In order to obtain the local MR relaxation rate values, we placed three-dimensional ROI over the injection sites and used the mean and standard deviation of the region to fit the correlation models. For all injection sites, we used the same fixed size ROI that encompasses the region of hypointensity. The use of predefined region has several advantages over the commonly used intensitybased segmentation. First, it avoids bias, as different intensity thresholds for segmentation can result in vastly different areas. In addition, normalization of disparate areas across scans is very difficult. Using fixed ROI, we did not need to make subjective decisions about the region boundaries. Also, we were able to use the mean relaxation rate value of the region directly as all regions were of the same size. It is important to note that our method will compute similar mean values of small regions with high relaxation rates and large regions with lower relaxation rates. Nonetheless, the relaxation rate distributions of those two hypothetical regions will have different standard deviations. Also, it is most likely that the two regions have similar total iron in the tissue and number of viral particles. Similar mean is therefore in agreement of our quantification methodology.
In addition to establishing the minimum therapeutic viral load, non-invasive measurements of gene expression should take into account the reporter sensitivity. Ferritin is a 'probeless' reporter and upon its transgene expression it loads the bioavailable iron from the cell cytoplasm utilizing proteins from the cellular iron import pathways. 24 A detailed discussion of the sensitivity of the ferritin reporter is described elsewhere. 40 At physiologically relevant iron loads, an increase in ferritin concentration results in a linear growth of MRI contrast-to-noise ratio. 40 The effect of ferritin overexpression on MRI contrast is even higher in vivo than predicted by models 40 owing to intracellular molecular aggregation and lower water diffusion rates in tissues. 25 Overall, compared with PET and SPECT, MRI requires a larger number of reporter molecules in order to detect gene expression. 26 However, many in vivo gene therapy applications require a high dose for effective therapy, 2 thus, the drawback of modest sensitivity may not be a limiting factor.
In this study, both R 2 and R 2 * were analyzed. The local R 2 change was approximately linear as a function of viral dose (Figure 6a) , and therefore this parameter may be useful for indirect quantification of transgene expression. On the other hand, the R 2 * was better described by exponential saturation behavior (Figure 6b ). R 2 * also provided more reliable discrimination at low viral doses, and thus may be better suited for detecting the reporter expression from small viral doses (Figure 7b) .
The future development of non-invasive measurement of gene expression lies in the combination of different imaging modalities in order to leverage their respective strengths to help overcome their weaknesses. For example, others 22 have expressed ferritin using a lentivirus that was conjugated to a radionuclide that provided dual imaging of virus biodistribution and transduction pattern in a rat brain via SPECT and MRI. Optical imaging combined with MRI of ferritin has also been demonstrated. 23, 37 Relaxation rate measurements can be coupled with dosedependent inducible promoters providing quantification of gene expression with temporal control. 1, 5 Overall, we believe that the present study provides a meaningful framework for the further development of ferritin expression as an in vivo MRI gene reporter as well as its application for monitoring the effectives of therapeutic strategies.
MATERIALS AND METHODS
Viral vectors
We used HSV-1 replication incompetent vectors produced as previously described. 33 The LacZ control vector has deletion of two essential infectedcell polypeptide (ICP) genes, ICP4 and ICP27, with ICP22 and ICP47 expressed only during virus replication; in this construct, LacZ is placed in the UL41 locus and eGFP is the ICP27 locus. The HFt vector has the human HFt cassette in the UL41 locus replacing LacZ, otherwise it is isogenic to control vector. The molecular clone of human HFt was kindly provided by Paolo Arosio, University of Brescia, Italy. All transgenes utilize high-level constitutive cytomegalovirus promoter with a Simian virus 40 (SV40) poly(A) tail. The HFt vector titer was 2 Â 10 10 pfu ml À 1 , and the LacZ vector titer was 1.2 Â 10 11 pfu ml Western blotting B103 rat neuroblastoma cells were transduced with the HSV-1 vectors at a multiplicity of infection equal to 5. Cells expressing HFt and LacZ were harvested at 48 h post-transduction and lysed in a detergent solution containing protease inhibitor cocktail and EDTA (Pierce). Total protein content was measured using the BCA assay kit (Pierce). Equivalent amounts of clarified samples were resolved on 4-20% polyacrylamide gradient gels using reducing SDS-PAGE (sodium dodecyl sulfatepolyacrylamide gel electrophoresis) conditions and visualized using chemiluminescence.
Animal experiments
All animal experiments were approved by the Carnegie Mellon Institutional Animal Care and Use Committee (IACUC). Adult male C57BL mice (Harlan, Indianapolis, IN, USA), 5-7-weeks old, were anesthetized using intraperitoneal cocktail of ketamine and xylazine and placed in a head stereotactic device. We injected 5 ml of HFt vector inoculum unilaterally into the striatum (n ¼ 12). We gradually decreased the number of infectious particles in the inoculum, from 100 million to 12.5 million viral particles, by serial dilutions using phosphate-buffered saline until the MRI contrast produced by the HFt expression was indistinguishable from the contralateral control. The contralateral side was injected with the same volume of the LacZ expressing control virus (same number of viral particles). At 4 days post-injection, mice were imaged in vivo and then perfused intracardially with phosphate-buffered saline followed by 4% paraformaldehyde. The brains were excised and imaged at 11.7 T using a Bruker micro-imaging system (Bruker Biospin, Billerica, MA, USA). The brains were then flash frozen in optimal cutting temperature compound (EMS, Hatfield, PA, USA) and stored at À 80 1C for histology.
MRI and data analysis
We acquired 3D multi-echo spin-echo (MSE) images with 16 echoes, with first echo TE ¼ 10 ms, an inter-echo time of 10 ms, TR ¼ 2000 ms, and number of excitations (NEX) ¼ 2. The field of view was 15 Â 15 Â 25 mm, matrix size 256 Â 128 Â 128 and voxel size 0.6 Â 0.1 Â 0.2 mm. In addition, we acquired multi-echo gradient-echo (MGE) images with 8 echoes, with a first echo TE ¼ 3 ms, and an inter-echo time of 5 ms, TR ¼ 1200 ms, and NEX ¼ 2. For MGE, we used the same field of view and matrix size as the MSE. Images were fit on a voxel-by-voxel basis to a single exponential relaxation decay curve by applying a linear transformation using Matlab software (Natick, MA, USA). The procedure resulted in 3D maps of transverse relaxation rates R 2 ¼ 1/T 2 and R 2 * ¼ 1/T 2 *. In order to evaluate the local relaxation rates numerically, 3D ROI over the injection site were drawn on the second TE image using Amira software (Visage Imaging, San Diego, CA, USA). The ROI was fixed at 10 Â 20 voxels in-plane over five continuous slices, covering a total of 12 mm 3 brain tissue. We used the same size ROI for all the injection sites. The ROIs were then transferred to the corresponding R 2 and R 2 * maps. The mean and the standard deviations were computed from the R 2 and R 2 * distribution over each ROI. Each point on the regression fit represents the mean relaxation rate of a single injection site bounded by the ROI. Linear regression and saturating exponential models were applied to correlate the mean relaxation rates with the amount of infectious viral particles inoculated using Origin 7.5 software (Northampton, MA, USA).
Immunofluorescence and immunohistochemistry B103 cells were grown on glass bottom plates and transduced with HSV-1 vector expressing HFt and LacZ. At 48 h post-transduction, the cells were washed with phosphate-buffered saline and fixed using 4% paraformaldehyde. The cells were then probed using antigen-specific antibodies followed by the secondary reagents described above. After immunostaining, nuclei were stained with Hoechst 33342 (H3570, Invitrogen).
The brains of the animals were prepared for histological studies to assay transgene expression, viral proteins, and cytotoxicity. Frozen brain tissue was cryosectioned in 20 mm thick slices and incubated for 1 h at room temperature with primary antibodies in a humidified chamber, washed, and incubated for 45 min with secondary antibodies. For the Perls' iron staining, slices were immersed in water with 2% potassium ferrocyanide and 2% concentrated hydrochloric acid for 30 min. Cell nuclei were counterstained with 0.5% nuclear fast red (H-3403, Vector Labs, Burlingame, CA, USA). The X-gal stain for detection of b-galactosidase activity was performed using 5-bromo-4-chloro-3-indolyl b-D-galactopyranoside (B4252, Sigma-Aldrich).
Confocal microscopy
Fixed cells or tissue slices (described above) were washed and mounted with glass cover slips. Images were acquired using a Carl Zeiss LSM 510 Meta UV DuoScan (Thornwood, NY, USA) inverted confocal laserscanning microscope. Red, green and blue channels were collected sequentially with matrix a resolution of 1024 Â 1024 and two averages. Color channel overlay was performed using ImageJ. 41 
Statistical analysis
The significance of the linear regression model and the exponential model for the MRI quantification was calculated using Origin 7.5 software with a confidence interval of 0.95. The goodness of fit was evaluated using the R 2 value. The Shapiro-Wilk normality test was used to determine whether or not the residuals from the linear regression follow a normal distribution. For the reporter sensitivity measurements, we used a paired Student's t-test with a confidence interval of 0.95.
